← Eichor
Condition: Renal Cell Carcinoma Stage I Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Renal Cell Carcinoma Stage I

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Se
Phase 1 · 3 location(s) · Molecure S.A. · NCT05759923A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and U
NA · 1 location(s) · University of Washington · NCT06040762GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Phase 1 · 2 location(s) · Canadian Cancer Trials Group · NCT07297667A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · 69 location(s) · Shanghai Henlius Biotech · NCT07160335Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Phase 1 · 2 location(s) · LaunXP Biomedical Co., Ltd. · NCT06883539A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Phase 1 · 1 location(s) · Jemincare · NCT06321250Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell
Phase 1/Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT06866262IDOV-Immune for Advanced Solid Tumors
Phase 1 · 5 location(s) · ViroMissile, Inc. · NCT06910657[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors,
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06479811A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1 · 1 location(s) · Weijia Fang, MD · NCT05518253Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Phase 1/Phase 2 · 5 location(s) · Oncorena AB · NCT05287945Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · 1 location(s) · SAPU NANO (US) LLC · NCT07369505Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
Phase 1/Phase 2 · 2 location(s) · Jonsson Comprehensive Cancer Center · NCT06432036Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refr
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT07072234IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 · 1 location(s) · Grit Biotechnology · NCT06819293CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
Phase 1 · 1 location(s) · Osel, Inc. · NCT06399419TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Portage Biotech · NCT04969315A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Phase 1 · 13 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT06839105A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Phase 1/Phase 2 · 4 location(s) · Cancer Research UK · NCT06380816To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal C
Phase 1 · 1 location(s) · Hrain Biotechnology Co., Ltd. · NCT07647744Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05703854Autologous Dendritic Cell Vaccine in Kidney Cancer
Phase 2 · 1 location(s) · Jodi Maranchie · NCT05127824A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 13 location(s) · AstraZeneca · NCT07115043Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05665361GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/Phase 2 · 4 location(s) · GeneMedicine Co., Ltd. · NCT06265025Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT07584499Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant
Phase 1/Phase 2 · 1 location(s) · State University of New York at Buffalo · NCT06222593
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.